A rapid test device for the detection of IgG and IgM antibodies to SARS-Cov-2 in whole blood, serum, or plasma samples. This test is used for COVID-19 diagnosis and can be performed on multiple sample types.
Manufactured by
Hangzhou Realy Tech Co., Ltd
Hangzhou, China
REALY has a dedicated development facility with a large pool of experienced scientists who are committed to development of IVD Reagents. Our R D scientists are engaged in process development process improvement, formulation and analytical development.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
AssureTech.(Hangzhou) Co.,Ltd.
China · 5 relevant products
Innovation Biotech (Beijing) Co., Ltd
China · 3 relevant products
TERSACO AG
Switzerland · 1 relevant product
68 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 113 closest product alternatives
AssureTech.(Hangzhou) Co.,Ltd. · China
Rapid immunochromatographic test device for qualitative detection of COVID-19 IgG and IgM antibodies in human serum, plasma, or whole blood samples. Designed for point-of-care testing in clinical settings, providing results within minutes to support COVID-19 diagnosis and serological screening.
Innovation Biotech (Beijing) Co., Ltd · China
Rapid immunochromatographic test device for qualitative detection of SARS-CoV-2 IgM and IgG antibodies in human serum, plasma, or whole blood. Provides results within 15-20 minutes, enabling quick identification of COVID-19 infection status in clinical and point-of-care settings.
TERSACO AG · Switzerland
Rapid immunoassay test for qualitative detection of SARS-CoV-2 IgG and IgM antibodies in human serum or plasma. Designed for quick serological screening and diagnosis of COVID-19 infection status. Results available within minutes with sensitivity up to 4x higher than manual testing methods.
110 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products